Table 2 Clinicopathological and prognostic characteristics of epithelioid rhabdomyosarcoma
Study | Age (Y)/Sex | Size (cm) | Location | Rec/Met | Treatment | Follow-up (Mon) | Outcome |
|---|---|---|---|---|---|---|---|
Suarez-Vilela/2004 | 70–75/M | 5.5 | Retroauricular & SM | LN | Exc, Ch | 3 | DD |
Fujiwaki/2008 | 50–55/F | 6.5 | Fallopian tube | LN | Exc, Ch | 6 | DD |
Bowe/2011 | 70–75/M | 5 | Parotid gland LN | No | Exc, Ch | 12 | AWND |
Jo/2011 | 70–75/M | NA | Knee | L, LN | Exc, CR | 10 | DD |
Jo/2011 | 70–75/M | 5.3 | Neck | LN | Exc, Ch | 5 | DD |
Jo/2011 | 75–80/F | NA | Neck | Med, LN | Rad | 2 | DD |
Jo/2011 | 30–35/M | 8 | Arm | L, bone | Exc, CR | 60 | DD |
Jo/2011 | 20–25/M | 8.5 | Thigh | L, Liver | Exc, Ch | 6 | DD |
Jo/2011 | 10–15/F | NA | Elbow | No | Exc, CR | 47 | AWND |
Jo/2011 | 35–40/M | 8 | Forearm | L, LN | Exc, CR | 10 | DD |
Jo/2011 | 75–80/M | 8 | Shoulder | L | Exc | 24 | DD |
Jo/2011 | 70–75/M | 5 | Chesk wall | No | Exc, Ch | 36 | AWND |
Zin/2014 | 5–10/M | NA | Para-meningeal | LN | Exc, Ch | 96 | AWND |
Zin/2014 | 5–10/M | 3.3 | Para-meningeal | NA | Exc, Ch | 120 | AWND |
Zin/2014 | 10–15/F | 4 | Arm | No | Exc, Ch | 72 | AWND |
Zin/2014 | 5–10/F | 8.3 | Arm | LN | Exc, Ch | 24 | AWND |
Zin/2014 | 5–10/M | 4 | Orbit | No | Exc, Ch | 48 | AWND |
Yu/2015 | 15–20/F | 15 | Left thigh | NA | NA | 4 | DD |
Yu/2015 | 75–80/M | 12 | Left waist & back | Rec | Exc, Rad | 13 | AWND |
Yu/2015 | 60–65/M | 12.5 | Left chesk wall | LN | Exc | 2 | AWND |
Yu/2015 | 55–60/M | 2.5 | Left femur | L | Exc, Ch | 14 | DD |
Yu/2015 | 80–85/F | NA | Left upper eyelid | Preaurical | Exc | 7 | DD |
Yu/2015 | 35–40/M | 3.5 | Thyroid gland | No | Exc, CR | 6 | AWND |
Jokoji/2015 | 65–70/F |  | Neck & abdomen | LN | Ch | 6 | DD |
Renshaw/2019 | 50–55/F | NA | Pleural & L & RP | NA | NA | 21(Days) | DD |
Valerio/2020 | 80–85/M | 3 | Neck cutaneous | NA | NA | 0 | DD |
De Aguiar/2020 | 15–20/M | 6 | Jaw | NA | Exc, Ch | 5 | DD |
Rodgers/2021 | 70–75/M | 11.5 | Pelvic | LN | No | 5(Days) | DD |